| Literature DB >> 26892784 |
You Xu1, Hao Chai2, Bingren Zhang3, Qianqian Gao4, Hongying Fan5, Leilei Zheng6, Hongjing Mao7, Yonghua Zhang8, Wei Wang9,10.
Abstract
BACKGROUND: The exact cerebral structural and functional mechanisms under the auditory verbal hallucinations (AVHs) in schizophrenia are still unclear. The Deutsch "high-low" word illusion might trigger attentional responses mimicking those under AVHs.Entities:
Mesh:
Year: 2016 PMID: 26892784 PMCID: PMC4758162 DOI: 10.1186/s12888-016-0747-3
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Demographic data in patients with schizophrenia (n = 16) and healthy volunteers (n = 16)
| Schizophrenia | Controls | |
|---|---|---|
| Gender (f/m) | 5/11 | 9/7 |
| Age (in years; mean ± SD/ range) | 22.4 ± 5.8/16–36 | 20.4 ± 1.6/19–25 |
| Positive and negative syndrome scale (mean ± SD) | ||
| Total | 59.6 ± 13.7 | – |
| Positive scale | 14.4 ± 4.4 | – |
| Negative scale | 9.8 ± 3.7 | – |
| General psychopathology scale | 31.2 ± 9.4 | – |
| Lack of action | 4.63 ± 1.78 | – |
| Thinking disorder | 9.31 ± 2.98 | – |
| Irritation | 5.69 ± 2.12 | – |
| Paranoid | 4.81 ± 1.38 | – |
| Depression | 9.81 ± 2.81 | – |
| Others | 9.38 ± 2.50 | – |
| Disease history (in months) | 2.1 ± 0.7 | – |
| Medication | ||
| olanzapine | 6 | – |
| risperidone | 3 | – |
| quetiapine | 1 | – |
Fig. 1ERP grand averages in controls and schizophrenia at nine electrode sites. Controls are presented in dashed (n = 16), and schizophrenia in solid (n = 16) lines
Latencies and amplitudes of ERP components to target stimuli in controls and schizophrenia
| Site | N1 | |||
| Latency | Amplitude | |||
| Controls | Schizophrenia | Controls | Schizophrenia | |
| F3 | 139.45 ± 21.76 | 141.46 ± 14.05 | −13.48 ± 7.99 | −9.18 ± 3.42 |
| Fz | 140.91 ± 21.14 | 147.02 ± 27.97 | −12.81 ± 5.02 | −8.63 ± 3.89* |
| F4 | 140.24 ± 19.10 | 143.72 ± 20.69 | −11.50 ± 4.09 | −8.55 ± 4.62 |
| C3 | 139.14 ± 21.19 | 146.22 ± 26.66 | −12.60 ± 4.41 | −9.96 ± 3.38 |
| Cz | 137.74 ± 17.17 | 144.21 ± 27.19 | −14.00 ± 6.06 | −9.52 ± 3.60* |
| C4 | 138.35 ± 16.93 | 144.27 ± 29.15 | −12.18 ± 4.60 | −9.18 ± 3.57* |
| P3 | 132.19 ± 17.84 | 140.55 ± 30.68 | −7.27 ± 2.79 | −5.74 ± 2.58 |
| Pz | 133.53 ± 18.37 | 141.77 ± 35.92 | −9.04 ± 3.45 | −5.34 ± 2.65** |
| P4 | 136.40 ± 19.74 | 139.88 ± 27.93 | −7.42 ± 2.55 | −4.93 ± 2.74* |
| P2 | ||||
| Latency | Amplitude | |||
| Controls | Schizophrenia | Controls | Schizophrenia | |
| F3 | 220.48 ± 27.61 | 225.81 ± 13.90 | 0.29 ± 4.57 | 1.84 ± 4.76 |
| Fz | 218.95 ± 27.64 | 225.57 ± 21.76 | 0.56 ± 6.98 | 2.15 ± 5.40 |
| F4 | 219.38 ± 28.54 | 225.45 ± 21.93 | 0.48 ± 5.78 | 0.83 ± 4.49 |
| C3 | 223.71 ± 28.28 | 229.54 ± 16.73 | 1.51 ± 6.63 | 2.85 ± 5.90 |
| Cz | 223.35 ± 33.24 | 229.05 ± 21.91 | 3.72 ± 10.13 | 4.75 ± 7.85 |
| C4 | 226.28 ± 33.57 | 229.60 ± 21.26 | 1.69 ± 6.86 | 1.97 ± 5.33 |
| P3 | 218.77 ± 29.20 | 230.63 ± 16.16 | 3.06 ± 4.93 | 2.71 ± 4.88 |
| Pz | 218.77 ± 28.97 | 223.92 ± 21.44 | 4.84 ± 6.91 | 5.33 ± 4.61 |
| P4 | 222.98 ± 31.98 | 225.38 ± 22.96 | 2.50 ± 5.00 | 2.59 ± 5.19 |
| N2 | ||||
| Latency | Amplitude | |||
| Controls | Schizophrenia | Controls | Schizophrenia | |
| F3 | 243.83 ± 38.62 | 269.53 ± 22.37* | −0.88 ± 4.58 | −2.39 ± 5.65 |
| Fz | 243.40 ± 37.07 | 270.57 ± 20.78* | −1.23 ± 7.39 | −2.01 ± 6.81 |
| F4 | 245.66 ± 35.07 | 267.82 ± 25.89 | −0.64 ± 6.02 | −2.90 ± 6.69 |
| C3 | 242.79 ± 38.83 | 268.98 ± 23.84* | 0.81 ± 6.42 | −0.08 ± 4.73 |
| Cz | 243.40 ± 38.78 | 272.89 ± 31.77* | 2.67 ± 9.83 | 1.09 ± 7.51 |
| C4 | 241.88 ± 35.60 | 265.32 ± 23.57* | 1.32 ± 6.68 | −0.62 ± 5.65 |
| P3 | 242.97 ± 39.60 | 266.05 ± 22.88 | 2.58 ± 5.54 | 0.12 ± 4.59 |
| Pz | 246.45 ± 35.50 | 269.96 ± 20.53 | 3.97 ± 7.69 | 2.08 ± 4.10 |
| P4 | 244.19 ± 39.32 | 264.35 ± 25.74 | 2.01 ± 5.50 | 0.25 ± 5.05 |
| P3 | ||||
| Latency | Amplitude | |||
| Controls | Schizophrenia | Controls | Schizophrenia | |
| F3 | 340.39 ± 19.76 | 333.29 ± 24.25 | 10.71 ± 9.06 | 4.85 ± 5.30* |
| Fz | 334.29 ± 21.32 | 335.00 ± 24.84 | 14.19 ± 6.63 | 6.10 ± 6.37** |
| F4 | 336.79 ± 20.98 | 335.42 ± 29.35 | 12.84 ± 5.12 | 5.50 ± 6.12** |
| C3 | 330.57 ± 28.50 | 324.07 ± 26.16 | 11.88 ± 5.81 | 4.18 ± 4.05** |
| Cz | 323.36 ± 36.69 | 320.84 ± 27.69 | 14.54 ± 7.98 | 5.61 ± 4.60** |
| C4 | 328.80 ± 31.31 | 329.26 ± 32.19 | 12.88 ± 5.58 | 4.96 ± 4.43** |
| P3 | 325.26 ± 29.55 | 328.16 ± 23.97 | 11.07 ± 4.13 | 4.70 ± 4.84** |
| Pz | 322.14 ± 31.82 | 328.47 ± 30.16 | 13.67 ± 5.46 | 6.16 ± 4.00** |
| P4 | 330.08 ± 27.20 | 330.24 ± 34.17 | 10.81 ± 4.49 | 5.18 ± 3.67** |
*p < .05, **p < .01 vs controls; sample sizes of controls and schizophrenia were both 16. Latencies (in ms) and amplitudes (in μV) were presented as mean ± SD
Fig. 2P3 source reconstruction (maximum intensity projections) in controls and schizophrenia
Fig. 3Source level statistical parametric maps displaying decreased P3 activations in schizophrenia vs controls. Significant P3 source reductions were at left inferior temporal cortex [MNI coordinates: x = −44, y = −2, z = −34, t = 3.14, p = 0.002]